-+ 0.00%
-+ 0.00%
-+ 0.00%
Novartis Pharmaceuticals CEO said in a conference call: Most of our growth after 2031 will come from our existing product pipeline and existing core brands.
Share
Listen to the news
Novartis Pharmaceuticals CEO said in a conference call: Most of our growth after 2031 will come from our existing product pipeline and existing core brands.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending